These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 43368)

  • 41. The neuromuscular and other blocking actions of 4,17a-dimethyl-4,17a-diaza-d-homo-5 -androstane dimethiodide (HS-342) in the anaesthetized cat.
    Marshall IG; Paul D; Singh H
    Eur J Pharmacol; 1973 May; 22(2):129-34. PubMed ID: 4715215
    [No Abstract]   [Full Text] [Related]  

  • 42. Effects of a new neuromuscular blocking agent (Org 9426) in anaesthetized cats and pigs and in isolated nerve-muscle preparations.
    Muir AW; Houston J; Green KL; Marshall RJ; Bowman WC; Marshall IG
    Br J Anaesth; 1989 Oct; 63(4):400-10. PubMed ID: 2573387
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The ganglion blocking and vagolytic actions of three short-acting neuromuscular blocking drugs in the cat.
    Marshall IG
    J Pharm Pharmacol; 1973 Jul; 25(7):530-6. PubMed ID: 4147049
    [No Abstract]   [Full Text] [Related]  

  • 44. Antagonism of Org NC 45 neuromuscular blockade by neostigmine, pyridostigmine, and 4-aminopyridine.
    Booij LH; van der Pol F; Crul JF; Miller RD
    Anesth Analg; 1980 Jan; 59(1):31-4. PubMed ID: 7188663
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interaction between pancuronium bromide and vecuronium bromide.
    Rashkovsky OM; Agoston S; Ket JM
    Br J Anaesth; 1985 Nov; 57(11):1063-6. PubMed ID: 2864945
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of experimental cholestasis on neuromuscular blocking drugs in cats.
    Westra P; Houwertjes MC; de Lange AR; Scaf AH; Hindriks FR; Agoston S
    Br J Anaesth; 1980 Aug; 52(8):747-57. PubMed ID: 7426252
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A new neuromuscular blocking drug, ORG NC 45. A pilot study in man.
    Baird WL; Herd D
    Br J Anaesth; 1980; 52 Suppl 1():61S-62S. PubMed ID: 6107108
    [No Abstract]   [Full Text] [Related]  

  • 48. Effects of changes in acid-base balance on neuromuscular blockade produced by ORG-NC 45.
    Funk DI; Crul JF; Pol FM
    Acta Anaesthesiol Scand; 1980 Apr; 24(2):119-24. PubMed ID: 6104411
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heart rate and blood pressure changes after ORG NC45 (vecuronium) and pancuronium during halothane and enflurane anesthesia.
    Gregoretti SM; Sohn YJ; Sia RL
    Anesthesiology; 1982 May; 56(5):392-5. PubMed ID: 6122389
    [No Abstract]   [Full Text] [Related]  

  • 50. Pharmacological study of a new competitive neuromuscular blocking steroid, pipecurium bromide.
    Kárpáti E; Biró K
    Arzneimittelforschung; 1980; 30(2a):346-57. PubMed ID: 6155921
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interactions between calcium entry blockers and vecuronium bromide in anaesthetized cats.
    Anderson KA; Marshall RJ
    Br J Anaesth; 1985 Aug; 57(8):775-81. PubMed ID: 2861838
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ORG NC 45: initial experiences.
    Swen J
    Br J Anaesth; 1980; 52 Suppl 1():66S-67S. PubMed ID: 6107112
    [No Abstract]   [Full Text] [Related]  

  • 53. Neuromuscular blocking effects of atracurium, vecuronium and pancuronium during bolus and infusion administration.
    Gramstad L; Lilleaasen P
    Br J Anaesth; 1985 Nov; 57(11):1052-9. PubMed ID: 2864943
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical use of vecuronium (ORG NC 45) in balanced anesthesia. Comparison with pancuronium.
    Thomas B; Rolly G; Huylenbroeck G; Beerens J
    Acta Anaesthesiol Belg; 1982; 33(3):167-76. PubMed ID: 6128860
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Age-dependent dose-response relationship of ORG NC 45 in anaesthetized patients.
    d'Hollander A; Massaux F; Nevelsteen M; Agoston S
    Br J Anaesth; 1982 Jun; 54(6):653-7. PubMed ID: 6123340
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nitroglycerin and the neuromuscular blockade produced by gallamine, succinylcholine, d-tubocurarine, and pancuronium.
    Glisson SN; Sanchez MM; El-Etr AA; Lim RA
    Anesth Analg; 1980 Feb; 59(2):117-22. PubMed ID: 6768318
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical study of pancuronium bromide as a neuromuscular blocking agent in anaesthesia.
    Telivuo L; Ertama P; Aalto-Setälä M; Appelqvist R; Kaljunen A; Karhunen U; Nuuttila K; Welling I
    Acta Anaesthesiol Scand; 1971 Dec; 15(4):261-6. PubMed ID: 4345074
    [No Abstract]   [Full Text] [Related]  

  • 58. Mechanisms underlying the prolonged duration of action of muscle relaxants caused by extrahepatic cholestasis.
    Westra P; Keulemans GT; Houwertjes MC; Hardonk MJ; Meijer DK
    Br J Anaesth; 1981 Mar; 53(3):217-27. PubMed ID: 6110432
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Pharmacology of various aminosteroidal muscle relaxants].
    Boumén U; Marshall I
    Farmakol Toksikol; 1989; 52(3):29-33. PubMed ID: 2571518
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical comparison of atracurium and vecuronium (Org NC 45).
    Robertson EN; Booij LH; Fragen RJ; Crul JF
    Br J Anaesth; 1983 Feb; 55(2):125-9. PubMed ID: 6131682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.